P499: THE PHASE 1B OMNIVERSE TRIAL OF ORAL AZACITIDINE IN COMBINATION WITH VENETOCLAX FOR TREATMENT OF RELAPSED/REFRACTORY OR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (TRIAL IN PROGRESS). (23rd June 2022) - Wei, A. H.; Carraway, H. E.; Taningco, L.; Laille, E.; Gong, J.; Prebet, T.; Lopes de Menezes, D.; Ravandi, F.